Gabapentin is an anticonvulsant medication that is used primarily to manage neuropathic pain and as an adjunct in the treatment of epilepsy. It functions by modulating calcium channel activity in the central nervous system to reduce neuronal excitability. The drug binds to the a2o subunit of voltage-gated calcium channels, which decreases the release of excitatory neurotransmitters. This binding leads to a reduction in the transmission of pain signals from peripheral nerves to the spinal cord. By lowering synaptic transmission, Gabapentin helps to alleviate chronic nerve pain and prevent seizure propagation. Its pharmacokinetic profile involves efficient absorption in the small intestine and subsequent distribution to neural tissues. The medication is eliminated primarily unchanged through renal excretion, with minimal metabolic transformation. Pharmacodynamically, the cumulative effect of repeated dosing stabilizes neuronal membranes and provides sustained analgesic and antiepileptic activity.

Gabapentin is an anticonvulsant medication primarily used to treat neuropathic pain and epilepsy. Its pharmacological profile includes dose-dependent absorption that becomes saturated at higher doses, leading to nonlinear pharmacokinetics. After oral administration the drug is minimally bound to plasma proteins and undergoes little hepatic metabolism. Pharmacodynamically it binds to the a2o subunit of voltage-gated calcium channels which reduces excitatory neurotransmitter release. This interaction diminishes neuronal hyperexcitability and decreases pain signaling in damaged peripheral nerves. As a result Gabapentin provides symptomatic relief for postherpetic neuralgia and diabetic peripheral neuropathy. The medication also helps prevent seizure propagation by limiting the release of excitatory substances at synaptic junctions. The overall effect of these mechanisms is a reduction in chronic neuropathic pain and an improvement in seizure control.

Some people taking Gabapentin experience drowsiness or dizziness. Others may notice mild nausea or constipation. Weight gain and swelling of the hands or feet are also reported. Headache and blurred vision can occur in certain individuals. Occasionally, users may feel tingling in the extremities. These effects are generally mild and often improve with continued use.

Gabapentin may cause drowsiness and fatigue in some individuals. Dizziness and lightheadedness are also reported by users. Some people experience coordination problems such as tremors or unsteady gait. Swelling of the hands and feet can occur as a side effect. Constipation and dry mouth are frequently observed symptoms. Visual disturbances like blurred vision have been noted in rare cases.